Public-Private Partnerships

Alcimed supported a consortium bringing together public bodies and private companies in the agricultural sector to target the theme of new technologies related to agriculture, providing it with a differentiation advantage to create value. Following an investigation and market study, we opted for a strategy around agricultural data and interoperability. We have also worked to build the conditions necessary for the deployment of an experimental public-private investment project intended to provide a POC on this theme.

Alcimed supported the strategic reflection to prepare for post-Fessenheim, in Haut-Rhin in France, by setting up an innovation hub bringing together public and private partners able to develop large-scale industrial projects in the field of energy transition. The innovation hub model created is at the crossroads of Carnot, IRT / ITE and existing structures in the Haut-Rhin territory.

Alcimed worked closely with public and private bodies of a leading French territory in health and medical technologies for the definition of the strategy for a world-class health campus. Our team brought its expertise in the field of healthcare and its current challenges and potentials to reach a relevant positioning. We then tested the attractiveness of this positioning directly with private decision-makers in the United States, Europe and Asia, to better define their expectations.

At Alcimed, we have been supporting several Carnot institutes in their development strategies. Our team assisted one of these institutes in defining its commercial process and in training its teams in the “sales posture” with the aim of strengthening the collaborations and contracts between this institute and private companies. Around twenty laboratory directors were trained in the sales posture during meetings, with the aim of increasing public private partnerships.

Alcimed supported a biotech company in understanding the strategic implications of bringing new therapies to market in a country that requires local manufacturing to enter the public healthcare market.

First of all, our team assessed the terms of previous public-private partnership deals as benchmarks for what could be expected at each level of development and commercialization. We analyzed  historically fruitful collaborations with other companies and  interviewed business development leaders. Then we structured a framework to approach the country’s government on suitable terms for both the public strucuture and the client, highlighting requirements and points of negotiation.

As a result, the client received a strategic plan on how to negotiate with the local stakeholders as well as advice on how to make a go/no go decision on future deals, based on the impact on IP protection and other strategic considerations.

Alcimed supported a pharma company to identify the most relevant public and semi-public funding opportunities to finance an R&D translational center in a specific region.

To do so, our team performed desk research to identify existing partnerships between pharma companies and public funding bodies in the region. Moreover, we mapped public funding opportunities for clinical and/or translational research. Finally, we interviewed KOLs to assess the interest of the local governments to collaborate with foreign companies and the attractiveness of the research ecosystem with a focus on specific technology areas.

Thanks to our work, our client could prioritize what country to target based on a thorough understanding of the research landscape and of the main public funding agencies sponsoring programs for translational research in each country.